… patient care and have facilitated more individualized therapy. Finally, we discuss novel
therapeutic targets and compounds for antiplatelet … Novel approaches for antiplatelet therapy …

… and safety of such a novel approach in acute settings where rapid platelet inhibition is
desirable, as for example in ACS patients [168,169]. Two other novel highly potent inhibitors of …

… To overcome these issues, novel approaches to ADP-axis inhibition have been explored.
Most notable are the direct P2Y 12 inhibitors, which were developed after explicit knowledge of …

… Current approaches to improving antiplatelet efficacy have relied … novel approaches for
antiplatelet therapies are being developed. Instead of simply developing more potent therapies, …

… Subsequently, a multi-center phase 2 double-blind randomized controlled trial (RCT) of
patients with a history of ischemic heart disease already receiving antiplatelet therapy with …

… antagonism of novel targets involved in platelet function could shape future antiplatelet
therapies that could ultimately lead to more effective or safer therapeutic approaches. In this …

… antiplatelet therapeutic and prophylactic strategies. The shift from a population-based approach
… associated with the different antiplatelet strategies, so that the right patient gets the right …

… dual therapy. We will also touch on the place of anticoagulation on top of antiplatelet therapy
in … Finally, we will consider whether personalised approaches to antiplatelet therapy may be …

… antiplatelet therapy. This review focuses on new antiplatelet drugs in development … a
potentially superior efficacy and safety profile compared to currently available therapies. …

… Thus, antiplatelet therapy with drugs able to interfere with … platelet reactivity, despite
antiplatelet therapy, is associated … Thus, antiplatelet therapy represents a cornerstone of ACS …